Kairous Acquisition Scores Extra 3 Months to Seal Wellous Group Deal

Kairous Acquisition announced today that its sponsor deposited $360,000 into trust to extend the SPAC’s merger deadline from today until March 16, 2023. The SPAC issued a convertible promissory note to the sponsor, which can opt to convert any portion of the loan into the SPAC’s units.

Kairous earlier this week announced a deal with Malaysia-based Wellous Group Limited, an Asia-based international nutrition company that develops, manufactures, markets and sells health and wellness products.

The merger consideration is $270 million, payable by newly-issued securities at $10.10 per share. Additional earnout shares may be issued to Wellous stockholders after closing, upon achievement of certain trading price-based and/or profitability targets.

Cash proceeds raised will consist of Kairous’s approximately $21 million in trust (assuming no redemptions). Read more.

Total
0
Shares
Related Posts
IPO
Read More

CA Healthcare Closes $115M IPO

The SPAC will target companies in the healthcare services, healthcare information technology, care management, behavioral health, medical devices, diagnostics, pharma services, health and wellness, and specialty pharmacy sectors.
Read More

Bilander Acquisition Will Redeem Stock and Wind Up

Shortly after its July 2021 IPO, the SPAC said it had been in discussions with potential business combination partners in their capacity as officers of TWC Tech Holdings II, an existing blank check company sponsored by an affiliate of Bilander's sponsor.